# Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Synthetic Tricalcium Phosphate and Autologous MMSCs

> **NCT02209311** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation** · enrollment: 12 (estimated)

## Conditions studied

- Partially Edentulous Maxilla
- Alveolar Bone Atrophy
- Alveolar Bone Loss

## Interventions

- **PROCEDURE:** Oral mucosa biopsy
- **PROCEDURE:** Sinus lift with implantation of tissue engineered construction
- **DEVICE:** Dental implant

## Key facts

- **NCT ID:** NCT02209311
- **Lead sponsor:** Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2017-10
- **Final completion:** 2018-03
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2016-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02209311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02209311, "Effectiveness and Safety of Method of Maxilla Alveolar Process Reconstruction Using Synthetic Tricalcium Phosphate and Autologous MMSCs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02209311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*